Aurora Cannabis (ACB) Payables (2018 - 2026)

Aurora Cannabis (ACB) has reported Payables for 9 consecutive years, with $36.9 million the latest figure, recorded in Q1 2026.

• Quarterly Payables fell 44.35% year-over-year to $36.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.9 million (down 44.35% YoY) and the FY2026 annual result came in at $36.6 million, down 46.5% from the prior year.
• Payables retreated to $36.9 million in Q1 2026 per ACB's latest filing, from $93.1 million in the prior quarter.
• Over the last five years, Payables for ACB reached as high as $108.0 million in Q4 2024 and fell as low as $36.9 million in Q1 2026.
• A 5-year average of $82.4 million and a median of $85.8 million in 2023 frame the typical range for Payables.
• Annual changes were most pronounced in 2024 — Payables surged 37.68% — and 2026, when it tumbled 44.35%.
• Year by year, Payables stood at $82.8 million in 2022, then rose by 13.15% to $93.7 million in 2023, then climbed by 15.25% to $108.0 million in 2024, then decreased by 13.8% to $93.1 million in 2025, then slumped by 60.36% to $36.9 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $36.9 million, $93.1 million, and $79.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.